Hyperlipidemia. Hyperlipidaemia, unspecified
Conditions
Interventions
Intervention 1: Intervention group: Patients in the intervention group receive a short message remind about the use of the drug for six weeks. Intervention 2: Control group: Patients in the control gr
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 65 Years
Inclusion criteria
Inclusion criteria: Being in the age group of 30 to 65 years, owning at least one mobile phone that has the ability to receive and send text messages, have reading and writing skills, the ability to send and receive text messages over mobile phones, and that the prescription for Patients only include oral medications
Exclusion criteria
Exclusion criteria: Diseases requiring drugs other than lipid metabolism, such as blood pressure, supplementary treatments such as herbal medicines, individual tendency to non-cooperation in research
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Increased adherence to drug use in patients with high blood lipids. Timepoint: At the beginning and end of the study. Method of measurement: Morisky questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Cholesterol,. Timepoint: The beginning and the end of the study. Method of measurement: Using the results of biochemical tests to determine the serum cholesterol level in mg / dl.;Triglycerides. Timepoint: The beginning and the end of the study. Method of measurement: Using the results of biochemical tests to determine the serum triglyceride level in mg / dl.;LDL. Timepoint: The beginning and the end of the study. Method of measurement: Using the results of biochemical tests to determine the serum LDL level in mg / dl. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyedeh Zeinab Mahdian
Iran University of Medical Sciences
Outcome results
None listed